Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
New Indicators Show Prescription Drug Spending Increased Slower than…
We have been hearing for years now that the pharmaceutical industry is the reason for the spike in healthcare costs,…
Virginia: The Latest (Failed) Attempt at Mandating Drug Pricing…
Virginia has joined the list of states with failed attempts at drug price transparency legislation in various states, as…
White House Budget includes Prescription Drug Cost Provisions and Publish…
Recently, the White House released its 2017 Budget through the Office of Management and Budget (OMB). In the Budget, the…
Testy Oversight and Government Reform Committee Hearing on Prescription…
The United States House Oversight and Government Reform Committee held a hearing on developments in the prescription…
Senators Wyden and Grassley Request Public Comments on Gilead Pricing
On the heels of their December 1, 2015, report on Gilead Sciences' pricing of Hepatitis C drugs Sovaldi and Harvoni,…
Problems Abound with Ohio Drug Price Ballot Petition
As you may recall, we have previously written about ballot initiatives in California and Ohio that are attempting to…
Pharmacy Benefit Managers Begin to Cut Ties With Specialty Pharmacies
Specialty pharmacies have been around since the 1970s, when they started to pop up to deliver products that required…
Medicare Releases Drug Data to the Public: Medicare Drug Spending Dashboard…
The Centers for Medicare and Medicaid Services (CMS) made drug cost data public for forty drugs administered by…
PhRMA Disowns Companies Like Valeant and Turing
CEO of Turing has more on his plate today than ever before, as Martin Shkreli was arrested for securities violations.…
Senate Aging Committee Hearing on Drug Prices: Faster Generics Approval…
The Senate Special Committee on Aging held a hearing on Wednesday, December 9, 2015, to discuss "Sudden Price Spikes in…